NP
Nirav Premji Haria
About Nirav Premji Haria
Data last updated:
Nirav Premji Haria is a Director at Cisb Dpb Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma and Real Estate and Construction. Earlier, Nirav Premji Haria was a Director at Alltime Constructions Private Limited (2006–2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cisb Dpb Pharmaceuticals Private Limited U46497MH2025PTC450626 | Director | 17 Jun 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Alltime Constructions Private Limited U45200MH2004PTC146718 | Director | 21 Jan 2006 | 2004 | ₹2.08 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nirav Premji Haria
| Name | DIN | Company | Designation |
|---|---|---|---|
| Krishna Narsingrao Pimple | 00831421 | Cisb Dpb Pharmaceuticals Private Limited | Non- Individual Subscriber |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirav Premji Haria
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirav Premji Haria
Nirav Premji Haria currently holds 1 directorship: Cisb Dpb Pharmaceuticals Private Limited (Director, since 17 Jun 2025).
Nirav Premji Haria was first appointed on 21 Jan 2006 as Director at Alltime Constructions Private Limited. The most recent appointment on record is 17 Jun 2025 at Cisb Dpb Pharmaceuticals Private Limited.
Nirav Premji Haria held 1 earlier board appointment: Alltime Constructions Private Limited (Director, 21 Jan 2006 to 21 Mar 2009).
The current boards of Nirav Premji Haria's companies include Krishna Narsingrao Pimple (Cisb Dpb Pharmaceuticals Private Limited).